Lista de obras - Alessandra Bearz - Dominio Público Uruguay

ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC).

artículo científico publicado en 2017

Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Third-Generation EGFR Tyrosine Kinase Inhibitor.

artículo científico publicado en 2017

Activity of crizotinib over choroidal metastases in non-small-cell lung cancer (NSCLC)-ALK rearranged: a case report.

artículo científico publicado en 2014

Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study

artículo científico publicado en 2006

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.

artículo científico publicado en 2015

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy

artículo científico publicado en 2008

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.

artículo científico publicado en 2016

Bevacizumab plus irinotecan-, fluorouracil-, and leucovorin-based chemotherapy with concomitant HAART in an HIV-positive patient with metastatic colorectal cancer.

artículo científico publicado en 2008

Cancer in the elderly: The caregivers’ perception of senior patients’ informational needs

artículo científico publicado en 2008

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

artículo científico publicado en 2017

Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

artículo científico publicado en 2017

Clinical Effectiveness and Cost-Effectiveness of Target Therapies for Adult Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review

artículo científico publicado en 2017

Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study

artículo científico publicado en 2009

Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting.

artículo científico publicado en 2007

Comment on 'Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection'.

artículo científico publicado en 2012

Concurrent chemoradiotherapy with tomotherapy in locally advanced Non-Small Cell Lung Cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimen

artículo científico publicado en 2013

Dose finding of ifosfamide administered with a chronic two-week continuous infusion.

artículo científico publicado en 2003

Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg).

artículo científico publicado en 2014

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

artículo científico publicado en 2012

FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature.

artículo científico publicado en 2008

FOLFOX2 regimen in the treatment of advanced colorectal cancer: a comparison between elderly and young patients

artículo científico publicado en 2006

Fatigue in cancer patients receiving chemotherapy: an analysis of published studies

artículo científico publicado en 2004

Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)

scientific article published on 24 October 2006

Immune checkpoint inhibitors and response analysis: a tough challenge. A case report

artículo científico publicado en 2016

Interleukin-2 continuous infusion and angiogenesis surrogate markers in metastatic renal cell carcinoma

artículo científico publicado en 2006

Malignant peritoneal mesothelioma: a multicenter study on 81 cases.

artículo científico publicado en 2009

Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective

artículo científico publicado en 2009

NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial

scientific article published on 09 May 2018

Neoplastic pericardial disease in lung cancer: Impact on outcomes of different treatment strategies. A multicenter study

artículo científico publicado en 2010

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience.

artículo científico publicado en 2018

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

artículo científico publicado en 2017

Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients.

artículo científico publicado en 2013

Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients

article

Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)

artículo científico publicado en 2011

Patient-Centered Cancer Care Programs in Italy: Benchmarking Global Patient Education Initiatives

artículo científico publicado en 2015

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.

artículo científico publicado en 2008

Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer

artículo científico publicado en 2008

Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.

artículo científico publicado en 2007

Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma

artículo científico publicado en 2006

Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer

artículo científico publicado en 2010

Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.

artículo científico publicado en 2014

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the eld

artículo científico publicado en 2005

Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.

artículo científico publicado en 2015

Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up

artículo científico publicado en 2013

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience.

artículo científico publicado en 2012

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy

artículo científico publicado en 2007

Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases

article

Small cell lung cancer in an elderly patient: efficacy of somatostatin analog treatment, a case report

artículo científico publicado en 2011

Solid pseudopapillary tumour of the pancreas

artículo científico publicado en 2003

Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b study.

artículo científico publicado en 2016

Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients

article

Staphylococcus cohnii septicaemia in a patient with colon cancer.

artículo científico publicado en 2003

Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer

artículo científico publicado en 2014

Target therapies in lung cancer

artículo científico publicado en 2011

Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.

artículo científico publicado en 2012

Treatment of elderly patients affected by lung cancer: why to treat, when to treat and what we know.

artículo científico publicado en 2013

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.

artículo científico

Lista de obras de Alessandra Bearz

ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC).

Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Third-Generation EGFR Tyrosine Kinase Inhibitor.

Activity of crizotinib over choroidal metastases in non-small-cell lung cancer (NSCLC)-ALK rearranged: a case report.

Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.

Bevacizumab plus irinotecan-, fluorouracil-, and leucovorin-based chemotherapy with concomitant HAART in an HIV-positive patient with metastatic colorectal cancer.

Cancer in the elderly: The caregivers’ perception of senior patients’ informational needs

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial

Clinical Effectiveness and Cost-Effectiveness of Target Therapies for Adult Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Review

Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study

Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting.

Comment on 'Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection'.

Concurrent chemoradiotherapy with tomotherapy in locally advanced Non-Small Cell Lung Cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimen

Dose finding of ifosfamide administered with a chronic two-week continuous infusion.

Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg).

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature.

FOLFOX2 regimen in the treatment of advanced colorectal cancer: a comparison between elderly and young patients

Fatigue in cancer patients receiving chemotherapy: an analysis of published studies

Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)

Immune checkpoint inhibitors and response analysis: a tough challenge. A case report

Interleukin-2 continuous infusion and angiogenesis surrogate markers in metastatic renal cell carcinoma

Malignant peritoneal mesothelioma: a multicenter study on 81 cases.

Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective

NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial

Neoplastic pericardial disease in lung cancer: Impact on outcomes of different treatment strategies. A multicenter study

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience.

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients.

Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients

Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)

Patient-Centered Cancer Care Programs in Italy: Benchmarking Global Patient Education Initiatives

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.

Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer

Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.

Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma

Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer

Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the eld

Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.

Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience.

Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy

Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases

Small cell lung cancer in an elderly patient: efficacy of somatostatin analog treatment, a case report

Solid pseudopapillary tumour of the pancreas

Sorafenib dose escalation in treatment-naïve patients with metastatic renal cell carcinoma: a non-randomised, open-label, Phase 2b study.

Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients

Staphylococcus cohnii septicaemia in a patient with colon cancer.

Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer

Target therapies in lung cancer

Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.

Treatment of elderly patients affected by lung cancer: why to treat, when to treat and what we know.

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.